Literature DB >> 17285603

Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.

Zhibin Hu1, Haifeng Wang, Minhua Shao, Guangfu Jin, Weiwei Sun, Yi Wang, Hongliang Liu, Ying Wang, Hongxia Ma, Ji Qian, Li Jin, Qingyi Wei, Daru Lu, Wei Huang, Hongbing Shen.   

Abstract

O6-alkylguanine-DNA alkyltransferase (MGMT) is a universal DNA repair protein involved in the DNA direct reversal repair pathway that copes with alkylating carcinogens. Reduced MGMT expression as well as enzyme activity may result in an increased susceptibility to cancers. To elucidate the role of sequence variation in MGMT in the etiology of lung cancer, we conducted a comprehensive association study focusing on linkage disequilibrium (LD) structure of common variations across the MGMT sequence and its modification effect on smoking-related lung cancer risk. We rebuilt the LD block of MGMT by genotyping 39 SNPs and selected a subset of 10 haplotype-tagging SNPs (htSNP) and three pre- and interblock SNPs to capture variation across MGMT. By using a haplotype-based multifactor dimensionality reduction (MDR) analysis, we found that there were significant more-than-multiplicative interactions between diplotypes in block 5 and cumulative smoking and additive interaction between genotypes of preblock SNP rs1625649:C>A and smoking status in relation on lung cancer risk. Diplotypes in block 3 and block 5, genotypes of rs1625649:C>A, and trichotomized cumulative smoking are the four factors included in the MDR-defined best model on lung cancer risk. When these variables were combined and dichotomized, we found that subjects carrying the combined risk stratum had a significantly increased risk for lung cancer of 4.10-fold (odds ratio [OR]=4.10, 95% confidence interval [CI]=3.12-5.37, P=2.09 x 10(-24)). These findings suggest that genetic variants in MGMT may modulate the risk of smoking-related lung cancer. This haplotype-based interaction analysis might provide a "proof-of-principle" approach for studying candidate genes in cancer susceptibility. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17285603     DOI: 10.1002/humu.20462

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  12 in total

1.  MGMT Leu84Phe gene polymorphism and lung cancer risk: a meta-analysis.

Authors:  Zhi-xiong Qiu; Fei Xue; Xuan-feng Shi; Xiao He; Hui-ni Ma; Lan Chen; Pin-zhong Chen
Journal:  Tumour Biol       Date:  2014-01-05

2.  Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.

Authors:  Zhengdong Zhang; Luo Wang; Sheng Wei; Zhensheng Liu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  DNA Repair (Amst)       Date:  2010-03-04

3.  MGMT DNA repair gene promoter/enhancer haplotypes alter transcription factor binding and gene expression.

Authors:  Meixiang Xu; Courtney E Cross; Jordan T Speidel; Sherif Z Abdel-Rahman
Journal:  Cell Oncol (Dordr)       Date:  2016-06-15       Impact factor: 6.730

4.  Genetic variants in N-myc (and STAT) interactor and susceptibility to glioma in a Chinese Han population.

Authors:  Delong Meng; Xiaoying Li; Shuo Zhang; Yingjie Zhao; Xiao Song; Yuanyuan Chen; Shiming Wang; Ying Mao; Hongyan Chen; Daru Lu
Journal:  Tumour Biol       Date:  2014-11-12

5.  Candidate variants at 6p21.33 and 6p22.1 and risk of non-small cell lung cancer in a Chinese population.

Authors:  Mingfeng Zhang; Lingmin Hu; Hao Shen; Jing Dong; Yongqian Shu; Lin Xu; Guangfu Jin; Tian Tian; Zhibin Hu; Hongbing Shen
Journal:  Int J Mol Epidemiol Genet       Date:  2009-07-26

6.  MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.

Authors:  Jee Hyun Park; Nung Soo Kim; Jae Yong Park; Yee Soo Chae; Jong Gwang Kim; Sang Kyun Sohn; Joon Ho Moon; Byung Woog Kang; Hun Mo Ryoo; Sung Hwa Bae; Gyu Seog Choi; Soo-Han Jun
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-21       Impact factor: 4.553

7.  Influence of promoter/enhancer region haplotypes on MGMT transcriptional regulation: a potential biomarker for human sensitivity to alkylating agents.

Authors:  Meixiang Xu; Ilona Nekhayeva; Courtney E Cross; Catherine M Rondelli; Jeffrey K Wickliffe; Sherif Z Abdel-Rahman
Journal:  Carcinogenesis       Date:  2013-10-25       Impact factor: 4.944

8.  Plasma Vitamin D Levels And Vitamin D Receptor Polymorphisms Are Associated with Survival of Non-small Cell Lung Cancer.

Authors:  Yao Liu; Wei Chen; Zhi-Bin Hu; Lin Xu; Yong-Qian Shu; Shi-Yang Pan; Jun-Cheng Dai; Guang-Fu Jin; Hong-Xia Ma; Hong-Bing Shen
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

9.  MGMT Leu84Phe polymorphism contributes to cancer susceptibility: evidence from 44 case-control studies.

Authors:  Jun Liu; Renxia Zhang; Fei Chen; Cuicui Yu; Yan Sun; Chuanliang Jia; Lijing Zhang; Taufiq Salahuddin; Xiaodong Li; Juntian Lang; Xicheng Song
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

Review 10.  Genetic Association Between Angiotensinogen Polymorphisms and Lung Cancer Risk.

Authors:  Hong Wang; Kun Zhang; Haifeng Qin; Lin Yang; Liyu Zhang; Yanyan Cao
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.